Exebacase, in Addition to Daptomycin against MRSA,Antimicrobial Agents and Chemotherapy

当前位置： X-MOL 学术 › Antimicrob. Agents Chemother. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Exebacase, in Addition to Daptomycin against MRSA
Antimicrobial Agents and Chemotherapy ( IF 4.1 ) Pub Date : 2021-08-16 , DOI: 10.1128/aac.00128-21
Razieh Kebriaei ₁ , Kyle C Stamper ₁ , Katherine L Lev ₁ , Taylor Morrisette ₁ , Jacinda C Abdul-Mutakabbir ₁ , Raymond Schuch ₂ , Dario Lehoux ₂ , Michael J Rybak _{1,

3,

4}

Affiliation

Exebacase is a lysin (cell wall hydrolase) with direct lytic activity against Staphylococcus aureus including methicillin-resistant S. aureus (MRSA). Time kill analysis experiments illustrated bactericidal activity of exebacase-daptomycin, against MRSA ...

中文翻译：